Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Pfizer, Searle pick Lally for new drugs

Published on .

Joint marketers Pfizer and the Searle division of Monsanto Co. have tapped Lally, McFarland & Pantello/Euro RSCG to serve as the launch agency for the next-generation of arthritis-treatment prescription drugs after Celebrex, executives close to the marketer said. Lally may play a role in giving the drugs brand names.

Copyright January 2000, Crain Communications Inc.

Most Popular
In this article: